Literature DB >> 26183624

Multiregional medical device development: regulatory perspective.

Atsushi Tamura1, Hiromu Kutsumi.   

Abstract

There are difficulties in conducting worldwide medical device development simultaneously because each country and/or region has their own medical device regulations. However, to aid globalization of the medical device market, and to quickly provide innovative medical devices to patients, attempts have been made to encourage harmonization and convergence of medical device regulations. 'Harmonization by doing' is a bilateral effort from the United States and Japan to develop global clinical trials and address regulatory barriers that may be impediments to timely device approval. The Global Harmonization Task Force (GHTF) was conceived in 1992 in an effort to achieve greater uniformity between national medical device regulatory systems. Since 2012, the GHTF has been replaced by the International Medical Device Regulators Forum.

Entities:  

Mesh:

Year:  2014        PMID: 26183624     DOI: 10.1007/s12328-014-0478-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  6 in total

Review 1.  APEC Harmonization Center: challenges and issues relating to multiregional clinical trials in the APEC region.

Authors:  K L Park; T G Kim; S K Seong; S Y Lee; S H Kim
Journal:  Clin Pharmacol Ther       Date:  2012-02-08       Impact factor: 6.875

2.  The academic research consortium governance charter.

Authors:  Mitchell W Krucoff; Roxana Mehran; Gerrit-Anne van Es; Ashley B Boam; Donald E Cutlip
Journal:  JACC Cardiovasc Interv       Date:  2011-05       Impact factor: 11.195

3.  Practical and statistical considerations on simultaneous global drug development.

Authors:  Ning Li; William Wang
Journal:  J Biopharm Stat       Date:  2012-09       Impact factor: 1.051

4.  Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective.

Authors:  Mitchell W Krucoff; Ralph G Brindis; Patricia K Hodgson; Michael J Mack; David R Holmes
Journal:  JACC Cardiovasc Interv       Date:  2012-07       Impact factor: 11.195

5.  Global cardiovascular device innovation: Japan-USA synergies: Harmonization by Doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions.

Authors:  Takahiro Uchida; Fumiaki Ikeno; Koji Ikeda; Yuka Suzuki; Koji Todaka; Hiroyoshi Yokoi; Gary Thompson; Mitchel Krucoff; Shigeru Saito
Journal:  Circ J       Date:  2013-03-29       Impact factor: 2.993

6.  The importance of Good Clinical Practice guidelines and its role in clinical trials.

Authors:  A Vijayananthan; O Nawawi
Journal:  Biomed Imaging Interv J       Date:  2008-01-01
  6 in total
  1 in total

1.  Proceedings from Heart Rhythm Society's emerging technologies forum, Boston, MA, May 12, 2015.

Authors:  Emily P Zeitler; Sana M Al-Khatib; David Slotwiner; Uday N Kumar; Paul Varosy; David R Van Wagoner; Gregory M Marcus; Fred M Kusumoto; Laura Blum
Journal:  Heart Rhythm       Date:  2016-02       Impact factor: 6.343

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.